Barings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,743
| Closed | -$602K | – | 240 |
|
|
2022
Q2 | $602K | Buy |
9,743
+2,366
| +32% | +$146K | 0.02% | 188 |
|
|
2022
Q1 | $438K | Buy |
+7,377
| New | +$472K | 0.01% | 209 |
|
|
2021
Q3 | – | Sell |
-5,313
| Closed | -$365K | – | 401 |
|
|
2021
Q2 | $365K | Sell |
5,313
-521
| -9% | -$34.8K | 0.01% | 336 |
|
|
2021
Q1 | $377K | Sell |
5,834
-581
| -9% | -$37.5K | 0.01% | 340 |
|
|
2020
Q4 | $374K | Sell |
6,415
-63,381
| -91% | -$3.82M | 0.01% | 323 |
|
|
2020
Q3 | $4.41M | Sell |
69,796
-16,449
| -19% | -$1.14M | 0.1% | 154 |
|
|
2020
Q2 | $6.45M | Hold |
86,245
| – | – | 0.22% | 93 |
|
|
2020
Q1 | $6.45M | Sell |
86,245
-4,425
| -5% | -$306K | 0.22% | 93 |
|
|
2019
Q4 | $5.89M | Buy |
90,670
+21,118
| +30% | +$1.38M | 0.16% | 129 |
|
|
2019
Q3 | $4.41M | Sell |
69,552
-5,982
| -8% | -$391K | 0.1% | 178 |
|
|
2019
Q2 | $5.1M | Sell |
75,534
-82,629
| -52% | -$5.44M | 0.11% | 161 |
|
|
2019
Q1 | $10.3M | Sell |
158,163
-2,952
| -2% | -$196K | 0.24% | 80 |
|
|
2018
Q4 | $10.1M | Buy |
161,115
+791
| +0.5% | +$55.3K | 0.18% | 91 |
|
|
2018
Q3 | $12.4M | Sell |
160,324
-10,343
| -6% | -$781K | 0.17% | 95 |
|
|
2018
Q2 | $12.1M | Buy |
170,667
+21,799
| +15% | +$1.54M | 0.17% | 97 |
|
|
2018
Q1 | $11.2M | Buy |
148,868
+11,832
| +9% | +$941K | 0.16% | 108 |
|
|
2017
Q4 | $9.82M | Buy |
137,036
+19,554
| +17% | +$1.48M | 0.13% | 128 |
|
|
2017
Q3 | $9.52M | Hold |
117,482
| – | – | 0.17% | 88 |
|
|
2017
Q2 | $8.31M | Sell |
117,482
-137,482
| -54% | -$9.15M | 0.24% | 84 |
|
|
2017
Q1 | $17.3M | Buy |
254,964
+102,122
| +67% | +$7.18M | 0.2% | 90 |
|
|
2016
Q4 | $10.9M | Buy |
152,842
+24,120
| +19% | +$1.79M | 0.27% | 35 |
|
|
2016
Q3 | $10.2M | Buy |
128,722
+13,600
| +12% | +$1.1M | 0.26% | 38 |
|
|
2016
Q2 | $9.6M | Sell |
115,122
-84,600
| -42% | -$7.51M | 0.25% | 48 |
|
|
2016
Q1 | $18.3M | Sell |
199,722
-2,100
| -1% | -$189K | 0.49% | 17 |
|
|
2015
Q4 | $20.4M | Buy |
201,822
+18,120
| +10% | +$1.89M | 0.51% | 15 |
|
|
2015
Q3 | $18M | Sell |
183,702
-18,940
| -9% | -$2.1M | 0.45% | 22 |
|
|
2015
Q2 | $23.7M | Buy |
202,642
+93,730
| +86% | +$10.2M | 0.72% | 17 |
|
|
2015
Q1 | $10.7M | Sell |
108,912
-40,540
| -27% | -$4.12M | 0.24% | 49 |
|
|
2014
Q4 | $14.1M | Buy |
149,452
+1,180
| +0.8% | +$122K | 0.31% | 37 |
|
|
2014
Q3 | $15.8M | Buy |
148,272
+59,950
| +68% | +$5.87M | 0.34% | 40 |
|
|
2014
Q2 | $7.32M | Buy |
88,322
+7,600
| +9% | +$592K | 0.22% | 100 |
|
|
2014
Q1 | $5.72M | Buy |
80,722
+42,300
| +110% | +$3.32M | 0.18% | 113 |
|
|
2013
Q4 | $2.89M | Sell |
38,422
-11,500
| -23% | -$801K | 0.12% | 197 |
|
|
2013
Q3 | $3.14M | Sell |
49,922
-19,100
| -28% | -$1.14M | 0.13% | 161 |
|
|
2013
Q2 | $3.54M | Buy |
+69,022
| New | +$3.6M | 0.16% | 131 |
|
Other funds holding GILD
Barings's GILD Position: Q3 2022 in Review
Barings sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 9,743 shares — an estimated $602K sold.
Barings first reported a position in GILD in Q2 2013 and held it in 35 quarters. The position peaked at $23.7M in Q2 2015. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.
- Barings reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
- Barings sold 9,743 Gilead Sciences shares in Q3 2022, an estimated $602K.
- Barings first reported a position in Gilead Sciences in Q2 2013 and held it in 35 quarters.
- Barings's Gilead Sciences position peaked at $23.7M in Q2 2015.
- 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.
Based on Barings's 13F filing for Q3 2022, filed 14 Nov 2022.